Ghent University Academic Bibliography

Advanced

Evaluation of human albumin use in a university hospital in Belgium

Annemie Somers UGent, Tieneke Bauters, Hugo Robays UGent, Marcus Bogaert and Francis Colardyn (2002) PHARMACY WORLD & SCIENCE. 24(3). p.111-116
abstract
In 1996 - 1997, a drug use evaluation (DUE) of human albumin was conducted in the Ghent University Hospital (Belgium) to determine the pattern and appropriateness of the albumin use. The DUE was followed by permanent review of the albumin consumption. This paper describes how the DUE was carried out and how the albumin use in our hospital changed over time. Method: The study was based on criteria for indications and end of treatment, accepted by consensus of the physicians prescribing albumin. Albumin treatment episodes were classified as appropriate or inappropriate according to these criteria. Results: For 115 treatment episodes in 90 patients, the researchers found 21 (18.3%) deviations from the developed criteria. After analysis, half out of them were considered as minor. Most deviations involved starting treatment too early (n = 17). Follow-up results indicated that the overall consumption of albumin dropped by 50.1% from 1994 to 1999, while the consumption of colloid solutions during the same period remained stable. Conclusion: A good compliance with internally developed criteria for indications and end of treatment with human albumin was observed. Discussion with the clinicians involved led to the development of stricter criteria and a continuous decrease in albumin consumption.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
drug use evaluation (DUE), drug administration, drug utilization review (DUR), human albumin, INTENSIVE-CARE UNIT, total quality assurance (TQA), criteria, Belgium, colloids
journal title
PHARMACY WORLD & SCIENCE
Pharm. World Sci.
volume
24
issue
3
pages
111-116 pages
Web of Science type
Article
Web of Science id
000176756000006
JCR category
CHEMISTRY, MULTIDISCIPLINARY
JCR impact factor
0.357 (2002)
JCR rank
90/118 (2002)
JCR quartile
4 (2002)
ISSN
0928-1231
DOI
10.1023/A:1016120917510
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
155697
handle
http://hdl.handle.net/1854/LU-155697
date created
2004-01-14 13:39:00
date last changed
2016-12-19 15:38:20
@article{155697,
  abstract     = {In 1996 - 1997, a drug use evaluation (DUE) of human albumin was conducted in the Ghent University Hospital (Belgium) to determine the pattern and appropriateness of the albumin use. The DUE was followed by permanent review of the albumin consumption. This paper describes how the DUE was carried out and how the albumin use in our hospital changed over time.
Method: The study was based on criteria for indications and end of treatment, accepted by consensus of the physicians prescribing albumin. Albumin treatment episodes were classified as appropriate or inappropriate according to these criteria.
Results: For 115 treatment episodes in 90 patients, the researchers found 21 (18.3\%) deviations from the developed criteria. After analysis, half out of them were considered as minor. Most deviations involved starting treatment too early (n = 17). Follow-up results indicated that the overall consumption of albumin dropped by 50.1\% from 1994 to 1999, while the consumption of colloid solutions during the same period remained stable.
Conclusion: A good compliance with internally developed criteria for indications and end of treatment with human albumin was observed. Discussion with the clinicians involved led to the development of stricter criteria and a continuous decrease in albumin consumption.},
  author       = {Somers, Annemie and Bauters, Tieneke and Robays, Hugo and Bogaert, Marcus and Colardyn, Francis},
  issn         = {0928-1231},
  journal      = {PHARMACY WORLD \& SCIENCE},
  keyword      = {drug use evaluation (DUE),drug administration,drug utilization review (DUR),human albumin,INTENSIVE-CARE UNIT,total quality assurance (TQA),criteria,Belgium,colloids},
  language     = {eng},
  number       = {3},
  pages        = {111--116},
  title        = {Evaluation of human albumin use in a university hospital in Belgium},
  url          = {http://dx.doi.org/10.1023/A:1016120917510},
  volume       = {24},
  year         = {2002},
}

Chicago
Somers, Annemie, TIENEKE BAUTERS, Hugo Robays, Marcus Bogaert, and Francis Colardyn. 2002. “Evaluation of Human Albumin Use in a University Hospital in Belgium.” Pharmacy World & Science 24 (3): 111–116.
APA
Somers, Annemie, BAUTERS, T., Robays, H., Bogaert, M., & Colardyn, F. (2002). Evaluation of human albumin use in a university hospital in Belgium. PHARMACY WORLD & SCIENCE, 24(3), 111–116.
Vancouver
1.
Somers A, BAUTERS T, Robays H, Bogaert M, Colardyn F. Evaluation of human albumin use in a university hospital in Belgium. PHARMACY WORLD & SCIENCE. 2002;24(3):111–6.
MLA
Somers, Annemie, TIENEKE BAUTERS, Hugo Robays, et al. “Evaluation of Human Albumin Use in a University Hospital in Belgium.” PHARMACY WORLD & SCIENCE 24.3 (2002): 111–116. Print.